SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2012 / Cilt: 42 - Sayı: 6

Urodynamic evaluation of acute effects of sildenafi l on voiding among males with erectile dysfunction and symptomatic benign prostate

Soner AKÇİN
Mürsel DAVARCI
Ahmet GÖKÇE
Eşref Oğuz GÜVEN
Mehmet İNCİ
Fatih Rüştü YALÇINKAYA
Mevlana Derya BALBAY
Pages
951–956
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, to determine the role of sildenafil in the treatment of BPH/LUTS, further studies with larger patient groups are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate the acute eff ects of sildenafi l citrate on micturition of men with erectile dysfunction and symptomatic benign prostatic hyperplasia using urodynamic parameters.
📊
Key Findings & Data:Materials and methods: Between June and December 2009, a total of 50 patients over the age of 40 participated in the study.
💡
Conclusion & Impact:However, to determine the role of sildenafil in the treatment of BPH/LUTS, further studies with larger patient groups are needed.
🔬Design:Survey & Empirical Study
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate the acute eff ects of sildenafi l citrate on micturition of men with erectile dysfunction and symptomatic benign prostatic hyperplasia using urodynamic parameters. Materials and methods: Between June and December 2009, a total of 50 patients over the age of 40 participated in the study. Th e patients were admitted to our hospital with erectile dysfunction and moderate to severe lower urinary symptoms with benign prostatic hyperplasia. To examine the sexual function of the participants, we used the IIEF-5 Sexual Health Inventory for Men questionnaire. Patients were randomly divided into 2 groups: a treatment group and a control group. A basal urodynamic evaluation was performed in both groups. Aft er the urodynamic evaluation, 50 mg of sildenafi l was given to the patients in the control group and 1 h later a second evaluation was performed. Following the urodynamic evaluation, a placebo was given to the patients in the control group and then a second evaluation was performed aft er 1 h. Results: A statistically signifi cant increase was seen in maximal fl ow and average fl ow (Qmax and Qave) aft er 1 hin the treatment group. Th e increase in the control group was not signifi cant. Conclusion: Based on the study fi ndings, we suggest that sildenafi l has an eff ect on micturition in the short term. However, to determine the role of sildenafil in the treatment of BPH/LUTS, further studies with larger patient groups are needed.

🔖

Cite This Article

AKÇİN, S., DAVARCI, M., GÖKÇE, A., GÜVEN, E. O., İNCİ, M., YALÇINKAYA, F. R., BALBAY, M. D. (2022). Urodynamic evaluation of acute effects of sildenafi l on voiding among males with erectile dysfunction and symptomatic benign prostate. Turkish Journal of Medical Sciences, Cilt: 42 - Sayı: 6, 951–956. https://ajindex.com/articles/611245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yalçınkaya FR, Gökçe A, Davarcı M, Güven EO, İnci M, Kartal SB et al. Th e impact of NIH-IV prostatitis on early post-operative outcomes of the impact of NIH-IV prostatitis on early postoperative outcomes of transurethral resection of the prostate in patients with symptomatic benign prostate hyperplasia. Turk J Med Sci 2011; 41: 515-519
  2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 7: 270: 83-90
  3. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004; 84: 935-86
  4. Gacci M, Bartoletti R, Figlioli S, Sarti E, Eisner B, Boddi V et al. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and aft er prostatectomy: a prospective study. BJU Int 2003; 91: 196-200
  5. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Thomas S et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436-42
  6. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002; 90: 836-39
  7. Mulhall JP, Guhring P, Parker M, Hopps C. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006; 3: 662-667
  8. Rostaing L, Tran-Van T, Ader JL. Increased glomerular fi ltration rate in kidney-transplant recipients who take sildenafi l. N Engl J Med 2000; 342: 1679-80
  9. Tinel H, Stelte-Ludwig B, Hutter J, Sandner P. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int 2006; 98: 1259-63
  10. Uckert S, Kuthe A, Jonas U, Stief CG. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 2001; 166: 2484-90
  11. Guven EO, Balbay MD, Mete K, Serefoglu EC. Urofl owmetric assessment of acute eff ects of sildenafi l on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia. Int Urol Nephrol 2009; 41: 287-92
  12. Kojima M, Inui E, Ochiai A, Naya Y, Ukimura O, Watanabe H. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol 1997; 157: 476-9
  13. Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etio